Neck Squamous Cell Carcinoma of Unknown Primary

subtype

Identifier: CI-CAN-00006121
Entity page: /cancer/neck-squamous-cell-carcinoma-of-unknown-primary ↗
Edges: 20

Neighbours: 11 drugs9 trials
Drawn: 20 of 20 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Neck Squamous Cell Carcinoma of Unknown Primary investigated in trials for …INVESTIGATED_IN_TRIALSderived11 of 11
→ investigated in trials for	Cetuximabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants

Neck Squamous Cell Carcinoma of Unknown Primary studied in …STUDIED_INderived9 of 9
→ studied in	NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT06995508Phase 2 · recruiting Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial · condition mapped ONTOLOGY_EXACT · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped ONTOLOGY_EXACT · 9 trials mapped (4 active)	—	—	Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT02538510Phase 1/Phase 2 · completed Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT02196168Phase 2 · terminated Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Neck Squamous Cell Carcinoma of Unknown Primary	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains